Digital Smoking Cessation Tools for HIV: Research and Impact
Digital smoking cessation tools HIV research highlights tailored interventions for people living with HIV. These tools improve reach and engagement in this high-risk group. Mobile-based digital therapeutics show promise for overcoming traditional…
Clinical Research on Cannabis Derivatives for Autism
Cannabis derivatives autism clinical trials indicate potential benefits for behavioral challenges and anxiety in autism spectrum disorder. Current evidence is limited by small sample sizes and varied outcome measures. Larger randomized controlled trials…
Understanding Internalising Symptoms and Cannabis Use Risk in Adolescents
Internalising symptoms cannabis use risk adolescents is a critical area of study in adolescent mental health. Adolescents with untreated anxiety and depression symptoms show increased risk for cannabis use initiation. Early intervention targeting these…
Endocannabinoid System & Adolescent Psychotic Disorder Risk
Adolescent cannabis use psychotic disorder risk is a growing concern with evidence linking cannabis exposure to increased psychiatric disorders. This risk spans psychotic, bipolar, depressive, and anxiety disorders. Understanding these associations is…
Clinical Insights from the AURORA Study on Insomnia and Cannabis Use
The aurora study insomnia cannabis research highlights how pre-trauma insomnia predicts increased cannabis use after trauma. This clinical research emphasizes the need for monitoring trauma survivors with sleep disturbances. Early insomnia management may…
Endocannabinoid System Sleep Research: Clinical Trial Evidence
This pilot study examined oral cannabinoids sleep clinical trial evidence in patients with insomnia disorder. The findings showed a reduction in total sleep time and changes in REM sleep. These results highlight the need for further research on oral…
CBD Dominant Cannabis Anxiety Relief: Study Insights
This CBD dominant cannabis anxiety relief study highlights the anxiolytic benefits of CBD-containing products over 30 days. Findings show significant anxiety reduction compared to THC-only products. The study emphasizes the importance of cannabinoid…
Endocannabinoid System Trauma Treatment and PTSD Research
Endocannabinoid system clinical research PTSD treatment reveals cannabis use does not impair trauma-focused therapy outcomes. Trauma-focused therapy remains effective for PTSD with substance use disorders. This research supports access to trauma-focused…
Endocannabinoid System and Pregnancy: Clinical Evidence
Prenatal alcohol exposure polysubstance use frequently occurs alongside other substances, increasing risks to fetal development. Understanding these patterns aids clinicians in screening and intervention. This study provides real-world data to guide…
Endocannabinoid System Clinical Research: Cannabis DKJ127 Trial
The Cannabis DK127 clinical trial demonstrated significant pain reduction in chronic low back pain patients using the full-spectrum cannabis extract VER-01. This phase 3 study showed sustained benefits over 12 weeks compared to placebo. The trial…